Metastatic Thymic Carcinoma B3 Thymoma clinical trials

Explore recruiting metastatic thymic carcinoma b3 thymoma clinical trials.

Also recruiting in Europe

Metastatic Thymic Carcinoma B3 Thymoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

“A Multicentric, Open-Label, Single Arm Phase II Study To Evaluate The Efficacy And Safety Of The Combination Of PEmbrolizumab And Lenvatinib In Pre-Treated Thymic CArcinoma PaTIents. PECATI”.

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Thymic Carcinoma B3 Thymoma trials by city

Metastatic Thymic Carcinoma B3 Thymoma in Toronto Metastatic Thymic Carcinoma B3 Thymoma in Vancouver Metastatic Thymic Carcinoma B3 Thymoma in Montreal Metastatic Thymic Carcinoma B3 Thymoma in Calgary Metastatic Thymic Carcinoma B3 Thymoma in Edmonton Metastatic Thymic Carcinoma B3 Thymoma in Ottawa Metastatic Thymic Carcinoma B3 Thymoma in Winnipeg Metastatic Thymic Carcinoma B3 Thymoma in Quebec City Metastatic Thymic Carcinoma B3 Thymoma in Hamilton Metastatic Thymic Carcinoma B3 Thymoma in Kitchener Metastatic Thymic Carcinoma B3 Thymoma in London Metastatic Thymic Carcinoma B3 Thymoma in Halifax Metastatic Thymic Carcinoma B3 Thymoma in New York Metastatic Thymic Carcinoma B3 Thymoma in Los Angeles Metastatic Thymic Carcinoma B3 Thymoma in Chicago Metastatic Thymic Carcinoma B3 Thymoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease